Louisiana kicks off PSE e-tracking
This article was originally published in The Tan Sheet
Executive Summary
Louisiana implements the National Precursor Log Exchange June 15 to monitor purchases of OTC products containing pseudoephedrine. Industry bears the cost of deploying and supporting NPLEx through the Consumer Healthcare Products Association, which advocates for electronic tracking of methamphetamine precursors over prescription-only status (1"The Tan Sheet" March 29, 2010, In Brief). Louisiana Gov. Bobby Jindal called NPLEx "a critical tool to help crack down on the sale of drugs that are used to produce meth." Kentucky and Illinois also fully implemented NPLEx. Alabama, Florida, Iowa, Kansas, Missouri, South Carolina and Washington State passed legislation to adopt the NPLEx system, but have yet to implement it, according to CHPA. Oklahoma and Arkansas use separate e-tracking systems. Oregon and Mississippi shifted PSE products to Rx-only availability
You may also be interested in...
California one step closer to e-tracking
The California Senate Safety Committee moves a bill that would implement a statewide, industry-funded electronic tracking system to monitor and block illegal sales of OTC medicines that contain the methamphetamine precursor pseudoephedrine. The Consumer Healthcare Products Association lauds the committee for passing AB 1455 "to fight domestic methamphetamine production while maintaining consumer access to important cold and allergy medications," according to a June 22 release. If the bill is enacted, California would join 11 other states that passed legislation to implement, or have already implemented, electronic tracking of OTC products with PSE (1"The Tan Sheet" June 21, 2010). Oregon and Mississippi made PSE containing products Rx only
Kansas selects NPLEx to track PSE purchases
Kansas becomes the fifth state to take up the Consumer Healthcare Products Association's offer to monitor methamphetamine precursor purchases at no cost to the state. Missouri, Illinois, Kentucky and Louisiana have already said they will implement the industry-funded National Precursor Log Exchange to help enforce purchase limits for pseudoephedrine-containing OTCs. CHPA announced the Kansas Board of Pharmacy's decision March 22. While Mississippi recently became the second state to make all PSE drugs available Rx only, CHPA hopes other states will elect to use the tracking system (1"The Tan Sheet" Feb. 8, 2010)
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”